European Society of Cardiology
 
  Login  Home About Us Contact Us Site Map
Search for
 Home > Knowledge Centre > Online Learning & Teaching > ESC Slide Resource > ESC Policy Conference on CVD in Women
Online Learning & Teaching
Webcasts
ESC Slide Resource
World Congress of Cardiology - ESC Congress 2006
ESC Congress 2005 Stockholm
ESC Congress 2004 Munich
ESC Congress 2003 Vienna
Management of CVD Risk in the Perimenopausal Woman 2006
EACPR Leuven Spring Meeting 2005
Heart Failure 2005
ESC Policy Conference on CVD in Women
Education in Heart
Educational Programme Resources
 
Scientific and Knowledge Search
Clinical Case Portal
Echocardiography
Heart Failure Scientific Reports
CME Calendar

Cost-effectiveness and resources allocation from a gender perspective

 Print version


Presentation title: Cost-effectiveness and resources allocation from a gender perspective
Author(s): B. Jonsson
Date: 23 June 2005
[Download complete file]
 
Click a thumbnail below to view an individual slide:



Cost-effectiveness and resource allocation from a gender perspective

Cost of cardiovascular disease
Cost of CVD in the US AHA 2004 Update. Billion $US
Cost of heart disease in Sweden An estimate for Sweden 1995. Million SEK

Life time cost of stroke in Sweden Excess cost per person in Euro
Cost of cardiovascular disease in Germany 2002. Billion euro
Cost of cardiovascular disease in Germany 2002. Million euro

Life time cost for treating women with CVD in the US
Cost-effectiveness in treating women at risk for heart disease
Lipid lowering in primary prevention

Risk for heart disease and life expectance at different ages for men and women in Sweden
Study Question
Assumptions Behind Calculations 1 Euro = 9.3 SEK

Threshold value for cost-effectiveness. Absolute 5-year risk (%)
Threshold value for cost-effectiveness How many will be treated (%)?
How many will be treated?

Discussion
Lipid lowering in secondary prevention
Cost per life year gained according to age, sex and cholesterol level. Direct costs

Cost per life year gained according to age, sex and cholesterol level. Direct + indirect costs
Conclusions
 
Sign up here to receive the My ESC News or ESC Newsletter
Submit an Abstract

There are no polls available right now.
Site Map | Contact Us | Terms & Conditions |  Privacy
 
Copyright © European Society of Cardiology 1997 - 2005 - All rights reserved